Literature DB >> 15747148

[Bavarian mammography screening program].

F Willgeroth1, M Baumann, D Blaser, A Crispin, S Froschauer, J de Waal, S Heywang-Köbrunner, D Hölzel, V Kääb, R Rothe, V Stich, S Thomaschewski, D Walter.   

Abstract

In Bavaria since the 1st April 2003 we have been conducting a high quality mammography-screening carried out in individual practises (BMS). We have used the European and the S 3 guidelines. The best diagnosis is an early diagnosis of the breast carcinoma to save human life. Because of this and the high mortality rate due to this disease it is essential to have a mammogram screening program. There is no single one ideal way of constructing a screening program, it is always based on compromise within the particular health care-systems. Arising problems cannot be avoided, it is only possible when all parties work closely together that the BMS works properly.

Entities:  

Mesh:

Year:  2005        PMID: 15747148     DOI: 10.1007/s00117-005-1182-5

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  10 in total

1.  Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.

Authors:  P P Rosen; C Kosloff; P H Lieberman; F Adair; D W Braun
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

2.  Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years.

Authors:  A B Miller; T To; C J Baines; C Wall
Journal:  J Natl Cancer Inst       Date:  2000-09-20       Impact factor: 13.506

3.  Breast cancer screening with mammography: overview of Swedish randomised trials.

Authors:  L Nyström; L E Rutqvist; S Wall; A Lindgren; M Lindqvist; S Rydén; I Andersson; N Bjurstam; G Fagerberg; J Frisell
Journal:  Lancet       Date:  1993-04-17       Impact factor: 79.321

4.  Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial.

Authors:  J Frisell; E Lidbrink; L Hellström; L E Rutqvist
Journal:  Breast Cancer Res Treat       Date:  1997-09       Impact factor: 4.872

5.  Is screening for breast cancer with mammography justifiable?

Authors:  P C Gøtzsche; O Olsen
Journal:  Lancet       Date:  2000-01-08       Impact factor: 79.321

6.  The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.

Authors:  N Bjurstam; L Björneld; S W Duffy; T C Smith; E Cahlin; O Eriksson; L O Hafström; H Lingaas; J Mattsson; S Persson; C M Rudenstam; J Säve-Söderbergh
Journal:  Cancer       Date:  1997-12-01       Impact factor: 6.860

7.  Reduced breast cancer mortality in women under age 50: updated results from the Malmö Mammographic Screening Program.

Authors:  I Andersson; L Janzon
Journal:  J Natl Cancer Inst Monogr       Date:  1997

8.  Update of the Swedish two-county program of mammographic screening for breast cancer.

Authors:  L Tabàr; G Fagerberg; S W Duffy; N E Day; A Gad; O Gröntoft
Journal:  Radiol Clin North Am       Date:  1992-01       Impact factor: 2.303

Review 9.  [Mammography and radiation risk].

Authors:  H Jung
Journal:  Rofo       Date:  1998-10

Review 10.  Overview of the biology and management of ductal carcinoma in situ of the breast.

Authors:  E R Frykberg; K I Bland
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

  10 in total
  2 in total

1.  [Are chest radiographs justified in pre-employment examinations? Presentation of legal position and medical evidence based on 1760 cases].

Authors:  S C Ladd; U Krause; M E Ladd
Journal:  Radiologe       Date:  2006-07       Impact factor: 0.635

2.  [Experiences of the Bavarian mammography screening program].

Authors:  J Nährig; H Höfler; S H Heywang-Köbrunner; N Prat; D Hölzel; P H Wünsch; A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.